India - English - Central Drugs Standard Control Organization

manas ph. - tab - 10

India - English - Central Drugs Standard Control Organization

manas ph. - tab - 10

Israel - English - Ministry of Health

megapharm ltd - flecainide acetate - solution for injection - flecainide acetate 10 mg/ml - flecainide - flecainide - serious sustained life threatening ventricular arrhthymias that have not respoded to other drugs.

Israel - English - Ministry of Health

bio-med - j.r ltd, israel - levosimendan - concentrate for solution for infusion - levosimendan 2.5 mg/ml - levosimendan - levosimendan - therapeutic indications: short-term treatment of acutely decompensated severe chronic heart failure.simdax should only be used as add-on therapy in situations where conventional therapy with e.g. diuretics, ace-inhibitors and digitalis is not sufficient and where there is a need for inotropic support.

Israel - English - Ministry of Health

rafa laboratories ltd - treprostinil as sodium - solution for injection - treprostinil as sodium 10 mg/ml - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

Singapore - English - HSA (Health Sciences Authority)

sanofi-aventis singapore pte. ltd. - milrinone lactate 1.427mg eqv milrinone 1.00mg - injection - 1mg - milrinone lactate 1.427mg eqv milrinone 1.00mg 1mg

Australia - English - Department of Health (Therapeutic Goods Administration)

regional health care group pty ltd - 61594 - central venous catheterization kit, short-term - the catheter consists of white radiopaque single or multi-lumen tubes which is tipped with soft blue material and has many side holes. each lumen of the catheter connects to an extension line so they can be connected to an administration line/transducer. the cvc sets are indicated for use by anaesthetists and intensivist?s in environments such as intensive care units, high dependency units, operating theatres, and resuscitation rooms in accident & emergency depts. and coronary care units. o the altius hp central venous catheter is a sterile, single use device indicated for use in attaining access to the central venous system. o central venous catheters are used for the purpose of: ? administration of vasoactive/inotropic drugs ? administration of incompatible medications ? administration of hypertonic solutions including total parenteral nutrition ? frequent blood sampling ? blood transfusion ? measurement of central venous pressure (cvp) ? power injection of contrast media

Australia - English - Department of Health (Therapeutic Goods Administration)

regional health care group pty ltd - 61594 - central venous catheterization kit, short-term - the catheter consists of white radiopaque single or multi-lumen tubes which is tipped with soft blue material and has many side holes. each lumen of the catheter connects to an extension line so they can be connected to an administration line/transducer. the cvc sets are indicated for use by anaesthetists and intensivist?s in environments such as intensive care units, high dependency units, operating theatres, and resuscitation rooms in accident & emergency depts. and coronary care units. the altius central venous catheter is a sterile, single use device indicated for use in attaining access to the central venous system. central venous catheters are used for the purpose of: - administration of vasoactive/inotropic drugs - administration of incompatible medications - administration of hypertonic solutions including total parenteral nutrition - frequent blood sampling - blood transfusion - measurement of central venous pressure (cvp)

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml;   - concentrate for infusion - 12.5 mg/ml - active: dobutamine hydrochloride 14 mg/ml equivalent to dobutamine 12.5 mg/ml, 250 mg dobutamine in 20 ml   excipient: hydrochloric acid sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin: a. acute heart failure acute myocardial infarction, cardiogenic shock, following cardiac surgery, medicine-induced depression of cardiac contractility such as that which occurs in excessive ?-adrenergic receptor blockade. b. chronic heart failure acute decompensation of chronic congestive heart failure, temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with conventional oral inotropic agents, systemic vasodilators, and diuretics. initially noncardiac in origin: acute hypoperfusion states secondary to trauma, surgery, sepsis, or hypovolaemia when mean arterial pressure is above 70-mm hg and pulmonary capillary wedge pressure is 18-mm hg or greater, with inadequate response to volume repletion and increased ventricular filling pressure, low cardiac output secondary to mechanical ventilation with positive end-expiratory pressure (peep). paediatric population: dobutamine is indicated in all paediatric age groups (from neonates to 18 years of age) as inotropic support in low cardiac output hypoperfusion states resulting from decompensated heart failure, following cardiac surgery, cardiomyopathies and in cardiogenic or septic shock. dobutamine stress echocardiography: dobutamine hydrochloride may be used as a substitute for physical exercise in stress testing in the diagnosis of coronary artery disease. precautions apply (refer to data sheet).

New Zealand - English - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml - concentrate for injection - 12.5 mg/ml - active: dobutamine hydrochloride 14.01 mg/ml equivalent to dobutamine 12.5 mg/ml excipient: hydrochloric acid nitrogen sodium hydroxide sodium metabisulfite water for injection - dobutamine hydrochloride is indicated when inotropic support is necessary for the treatment of patients with hypoperfusion states in whom cardiac output is insufficient to meet circulatory demands. dobutamine hydrochloride is also indicated when inotropic support is required for the treatment of patients in whom abnormally increased ventricular filling pressures introduce the risk of pulmonary congestion and oedema. conditions which may precipitate such situations include the following hypoperfusion states: initially cardiac in origin a. acute heart failure 1. acute myocardial infarction 2. cardiogenic shock 3. following cardiac surgery 4. medicine-induced depression of cardiac contractility such as that which occurs in excessive ?- adrenergic receptor blockade. b. chronic heart failure 1. acute decompensation of chronic congestive heart failure 2. temporary inotropic support in advanced chronic congestive heart failure, as an adjunct to therapy with convention